DE68912284D1 - Pyrazin-Derivate als Arneimittel zur Kontrolle und/oder Senkung des Serum Triglyzerid- und/oder- Cholesterolspiegels in Säugetieren. - Google Patents

Pyrazin-Derivate als Arneimittel zur Kontrolle und/oder Senkung des Serum Triglyzerid- und/oder- Cholesterolspiegels in Säugetieren.

Info

Publication number
DE68912284D1
DE68912284D1 DE89870154T DE68912284T DE68912284D1 DE 68912284 D1 DE68912284 D1 DE 68912284D1 DE 89870154 T DE89870154 T DE 89870154T DE 68912284 T DE68912284 T DE 68912284T DE 68912284 D1 DE68912284 D1 DE 68912284D1
Authority
DE
Germany
Prior art keywords
mammals
drugs
control
10alkyl
cholesterol levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89870154T
Other languages
English (en)
Other versions
DE68912284T2 (de
Inventor
Jun Karl H Beyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEYER JUN
Original Assignee
BEYER JUN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEYER JUN filed Critical BEYER JUN
Application granted granted Critical
Publication of DE68912284D1 publication Critical patent/DE68912284D1/de
Publication of DE68912284T2 publication Critical patent/DE68912284T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE89870154T 1988-10-21 1989-10-20 Pyrazin-Derivate als Arneimittel zur Kontrolle und/oder Senkung des Serum Triglyzerid- und/oder- Cholesterolspiegels in Säugetieren. Expired - Lifetime DE68912284T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/260,947 US4920123A (en) 1988-10-21 1988-10-21 Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals

Publications (2)

Publication Number Publication Date
DE68912284D1 true DE68912284D1 (de) 1994-02-24
DE68912284T2 DE68912284T2 (de) 1994-04-28

Family

ID=22991313

Family Applications (2)

Application Number Title Priority Date Filing Date
DE89870154T Expired - Lifetime DE68912284T2 (de) 1988-10-21 1989-10-20 Pyrazin-Derivate als Arneimittel zur Kontrolle und/oder Senkung des Serum Triglyzerid- und/oder- Cholesterolspiegels in Säugetieren.
DE198989870154T Pending DE370987T1 (de) 1988-10-21 1989-10-20 Pyrazin-derivate als arneimittel zur kontrolle und/oder senkung des serum triglyzerid- und/oder- cholesterolspiegels in saeugetieren.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198989870154T Pending DE370987T1 (de) 1988-10-21 1989-10-20 Pyrazin-derivate als arneimittel zur kontrolle und/oder senkung des serum triglyzerid- und/oder- cholesterolspiegels in saeugetieren.

Country Status (9)

Country Link
US (1) US4920123A (de)
EP (1) EP0370987B1 (de)
JP (1) JP2840089B2 (de)
KR (1) KR900005981A (de)
AT (1) ATE99936T1 (de)
AU (1) AU616313B2 (de)
CA (1) CA2001171C (de)
DE (2) DE68912284T2 (de)
ZA (1) ZA897966B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110817A (en) * 1988-10-21 1992-05-05 Beyer Jr Karl H Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US5622985A (en) * 1990-06-11 1997-04-22 Bristol-Myers Squibb Company Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6369103B1 (en) 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
US5801177A (en) * 1995-12-14 1998-09-01 Beyer, Jr.; Karl H. Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients
DE19622222A1 (de) * 1996-06-03 1997-12-04 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
BRPI0514600A (pt) 2004-08-24 2008-06-17 Uab Research Foundation métodos para a fabricação de um composto, para a purificação de um composto, para o tratamento de um indivìduo tendo uma condição neoplástica, tendo carcinoma de célula escamosa, e tendo carcinoma de célula basal, para a redução ou prevenção da ocorrência de uma condição neoplástica em um indivìduo, e para a redução de triglicerìdeos no soro em um indivìduo, composto, e, composição farmacêutica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274191A (en) * 1963-11-15 1966-09-20 Merck & Co Inc N-(3-aminopyrazinoyl) benzamidines and process for preparing
US4594349A (en) * 1982-01-04 1986-06-10 Beyer Jr Karl H Hyperuretic agents
US4604394A (en) * 1984-10-01 1986-08-05 Merck & Co., Inc. Antiarrhythmic compositions and method
GB8712368D0 (en) * 1987-05-26 1987-07-01 Erba Farmitalia Pyrazine n-oxide derivatives

Also Published As

Publication number Publication date
EP0370987A3 (en) 1990-12-19
EP0370987B1 (de) 1994-01-12
DE370987T1 (de) 1991-09-05
AU4290989A (en) 1990-04-26
KR900005981A (ko) 1990-05-07
ATE99936T1 (de) 1994-01-15
CA2001171C (en) 1999-12-21
CA2001171A1 (en) 1990-04-21
DE68912284T2 (de) 1994-04-28
JP2840089B2 (ja) 1998-12-24
JPH02237923A (ja) 1990-09-20
ZA897966B (en) 1990-08-29
AU616313B2 (en) 1991-10-24
US4920123A (en) 1990-04-24
EP0370987A2 (de) 1990-05-30

Similar Documents

Publication Publication Date Title
ATE247654T1 (de) Neue heterozyklische verbindungen
DE68912284D1 (de) Pyrazin-Derivate als Arneimittel zur Kontrolle und/oder Senkung des Serum Triglyzerid- und/oder- Cholesterolspiegels in Säugetieren.
OA09334A (fr) "Dérivés d'acides aminés".
DE3783988D1 (de) Zyklische enolderivate, herstellung und anwendung.
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
NO933450D0 (no) Antiarrytmiske og kardiobeskyttende substituerte 1(2h)isokinoliner, fremgangsmaater for deres fremstilling, medikament inneholdende disse og anvendelse derav for fremstillingav et medikament for aa bekjempe hjertefeil
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
ATE46335T1 (de) Piperazinverbindungen als paf-antagonisten.
DE3855325D1 (de) Oxothiolane und Derivate, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Arzneimittel
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
ATE92316T1 (de) Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien.
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
ES2068216T3 (es) Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.
NO160360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
FI914007A0 (fi) 4-substituerade dihydropyrido (4,3-d) pyrimidiner som smaertslindrande och lokala inflammationshaemmande medel vid vaord av hudsjukdomar.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
IL78954A0 (en) Spiro-imidazolidines and pharmaceutical compositions containing them
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DE3770321D1 (de) 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ES8505993A1 (es) Un metodo para preparar un derivado de 3-indolcarboxamida
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze

Legal Events

Date Code Title Description
8364 No opposition during term of opposition